Skip to content
← Full study record

NCT05655546 · OUTCOME

Cost of Care

ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals · Source last updated 2025-08-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEAN
Unit
dollars
Interval / dispersion
95% Confidence Interval
Time frame
During study participation (on average 12 months)

What was measured

Investigators will compare the cost of care for COVID-19 infections between the control and intervention arms.

Analysis population: Participants with claims and/or survey data were included.

Groups in this outcome

Intervention Arm

Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.

Control Arm

Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Intervention Arm310
Control Arm285

Reported measurements

Source class 1
Values in dollars · Interval/dispersion: 95% Confidence Interval
GroupValueSpreadLowerUpperComment
Intervention Arm2,022Not reported04,655Not reported
Control Arm5,740Not reported3,1078,373Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0
        upper Limit
        4,655
        value
        2,022
      2. group Id
        OG001
        lower Limit
        3,107
        upper Limit
        8,373
        value
        5,740
denoms
  1. counts
    1. group Id
      OG000
      value
      310
    2. group Id
      OG001
      value
      285
    units
    Participants
description
Investigators will compare the cost of care for COVID-19 infections between the control and intervention arms.
dispersion Type
95% Confidence Interval
groups
  1. description
    Participants in this group will complete the baseline study activities, as described above. Additionally, participants will be instructed to create a Cue Health account and download the Cue Health App. Using the app and the 10 Cue Health COVID-19 molecular tests that are provided (or Cue Health Flu+COVID molecular tests if available and FDA authorized), the participant will perform tests after exposure or if symptoms arise. Participants can also use the test for close contacts who are exposed to COVID-19 and/or have symptoms. If COVID-19 infection occurs, participants will have access to telemedicine to discuss further with a healthcare professional. When clinically indicated, medication for the treatment of COVID-19 (and/or Influenza in case of Cue Health Flu+COVID test availability) will be prescribed and delivered to the participants' delivery address. Participants can also seek care through other healthcare providers or not seek care, at their discretion.
    id
    OG000
    title
    Intervention Arm
  2. description
    Participants in the control group will complete the baseline study activities, as described above. If symptoms arise or COVID-19 infection occurs, participants will test and seek care as they normally would.
    id
    OG001
    title
    Control Arm
param Type
MEAN
population Description
Participants with claims and/or survey data were included.
reporting Status
POSTED
time Frame
During study participation (on average 12 months)
title
Cost of Care
type
PRIMARY
unit Of Measure
dollars

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice